美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Genomics Immunology and Healthcare ETF

38.70

+0.11150.29%

盤後：38.00-0.6967-1.80%19:32 EDT

成交量：3.30萬

成交額：128.02萬

市值：2.61億

市盈率：- -

高：39.05

開：38.74

低：38.31

收：38.59

52周最高：41.49

52周最低：22.33

股本：675.00萬

流通股本：675.00萬

量比：0.19

換手率：0.49%

股息：0.28

股息率：0.73%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

丹納赫（DHR）旗下兩子公司聯合推出Cas9 mRNA解決方案賦能基因編輯研發加速落地

Revolution Medicines宣佈Rasonque™（Daraxonrasib）聯合化療獲美國FDA突破性療法認定，用於一線轉移性胰腺癌治療

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

Moderna Inc(MRNA)股票9月11日盤中上漲8.63%：關鍵驅動因素揭曉

TradingKey中文

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IDNA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":38.7,"timestamp":1789588800000,"preClose":38.5885,"halted":0,"volume":32988,"hourTrading":{"tag":"盘后","latestPrice":38.0033,"preClose":38.7,"latestTime":"19:32 EDT","volume":2249,"amount":86735.3256,"timestamp":1789601541750,"change":-0.6967,"changeRate":-0.018003,"amplitude":0.018003},"delay":0,"changeRate":0.0028894618863132666,"floatShares":6750000,"shares":6750000,"eps":0,"marketStatus":"未開盤","change":0.1115,"latestTime":"09-16 16:00:00 EDT","open":38.74,"high":39.0501,"low":38.308,"amount":1280225.552088,"amplitude":0.019231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.5885,"sharesOutstanding":5100000,"nav":38.606949,"aum":262527253.2,"dividendRate":0.007279,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":38.06,"preClose":38.5885,"latestTime":"08:41 EDT","volume":102,"amount":3926.559972,"timestamp":1789562469274,"change":-0.5285,"changeRate":-0.013696,"amplitude":0.011402},"postHourTrading":{"tag":"盘后","latestPrice":38.0033,"preClose":38.7,"latestTime":"19:32 EDT","volume":2249,"amount":86735.3256,"timestamp":1789601541750,"change":-0.6967,"changeRate":-0.018003,"amplitude":0.018003},"volumeRatio":0.19317,"impliedVol":0.2388,"impliedVolPercentile":0.6892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.19317,"shares":6750000,"dividePrice":0.2817,"high":39.0501,"amplitude":0.019231,"preClose":38.5885,"low":38.308,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":38.7,"eps":0,"divideRate":0.007279,"volume":32988,"delay":0,"ttmEps":0,"open":38.74,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":38.6,"twentyDayClose":35.98,"sixtyDayClose":30.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667985488","title":"丹納赫（DHR）旗下兩子公司聯合推出Cas9 mRNA解決方案 賦能基因編輯研發加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985488","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667985488?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:57","pubTimestamp":1789563457,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丹纳赫 旗下两家子公司——集成DNA技术公司与Aldevron宣布推出联合研发的科研级S.p. Cas9 mRNA解决方案，涵盖野生型及SpyFi高保真两种形式，旨在加速CRISPR基因编辑项目从早期研究向符合CGMP标准的临床开发转型。该联合方案结合了IDT在CRISPR基因工程与设计方面的专业知识，以及Aldevron在mRNA领域的规模化生产能力。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306117","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366333091.USD","LU1923622614.USD","BK4534","LU0708995401.HKD","XT","LU0114720955.EUR","SYNB","TARK","CRSP","IE000M9KFDE8.USD","LU0432979614.USD","LU0689472784.USD","SG9999001176.USD","LU0390134368.USD","LU2106854487.HKD","BMED","BK4585","IE00BQXX3F31.USD","LU0289739343.SGD","LU1551013342.USD","SG9999004303.SGD","LU1267930730.SGD","WDNA","LU0289961442.SGD","LU1974910355.USD","IDNA","GNOM","LU2063271972.USD","DHR","FMED","LU2355687059.USD","DTEC","ARKG","NBDS","KOMP","LU0528227936.USD","FWD","LU2125910336.SGD","LU1804176565.USD","LU1551013425.SGD","LU1791710582.SGD","SGXZ57979304.SGD","LU0820561818.USD","LU2211814178.USD","LU0943347566.SGD","LU0289960550.SGD","HELX","LU0882574055.USD","IE00BQXX3C00.GBP","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165924054","title":"Revolution Medicines宣佈Rasonque™（Daraxonrasib）聯合化療獲美國FDA突破性療法認定，用於一線轉移性胰腺癌治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1165924054","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165924054?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:06","pubTimestamp":1789416374,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc.今日宣布，其研发的创新药物Rasonque与化疗药物联用，已获得美国食品药品监督管理局授予的突破性疗法认定。这一认定针对的适应症为一线治疗转移性胰腺癌。此项突破性疗法认定标志着该联合治疗方案在临床试验中展现出显著的治疗潜力，有望为预后极差的转移性胰腺癌患者带来新的治疗选择。这一进展不仅为Revolution Medicines的研发管线注入了强劲动力，也让医学界对攻克胰腺癌这一顽固性疾病增添了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","BK4139","BBH","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","IE0002141913.USD","CANC","IE0009354923.USD","IE00BJT1NW94.SGD","RVMD","PTH","IDNA","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNOM","SYNB","LU2322448791.USD","TMED","LFSC","HELX","LU1992135399.USD","PBE","BK4585","FTXH","BBH","CANC","LU2272731600.USD","LU2272731865.HKD","RSPH","PSCH","IBB","IDNA","IEIH","MRNY","XBIX","BK4588","FBT","BME","RXL","AZNH","LU2322448957.HKD","PJP","XPH","IEHS","LU2272731782.SGD","WDNA","IBRN","BIOY","LU2473716301.USD","IYH","MEDI","IE00B5TLWC47.USD","BBP","MRNX","LU1992135472.HKD","BIB","PPH","PBPH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657657","title":"Moderna Inc(MRNA)股票9月11日盤中上漲8.63%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657657","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 01:16","pubTimestamp":1789146984,"startTime":"0","endTime":"0","summary":"• 受机构买盘重新涌入及盘整巩固的推动，莫德纳出现上行波动。\n• intismeran autogene 的 3 期临床试验结果验证了其肿瘤学平台。\n• 最新年度营收为 19.4 亿美元，净亏损为 28.2 亿美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262164048-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4501","BK4568","IDNA","BK4533","GNOM","WDNA","BK4139","MRNX","BK4588","MRNA","BK4532","BK4551","BK4585","MRNY","BK4534","LGHT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IDNA\",params:#limit:6,delay:false,,,undefined,":[]}}